Skip to main content
Dupilumab improves eosinophilic esophagitis up to 24 weeks
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dupilumab improves eosinophilic esophagitis up to 24 weeks
User login
Username
Password
Reset your password
Concept
Lead
score
Otolaryngology
1
1
Esophagus
0
0.72
Eosinophilic Esophagitis
0
0.45
Dysphagia
0
0.32
Eosinophils
0
0.32
Esophagitis
0
0.32
Biologic Therapy
0
0.23
Topical Corticosteroid
0
0.23
Crohn Disease
0
0.19
Adolescent Medicine
0
0.16
Corticosteroids
0
0.16
Proton Pump Inhibitor
0
0.16
Ulcerative Colitis
0
0.16
Inflammatory Bowel Disease
0
0.11
Revenue and Practice Management
0
0.11
Adherence
0
0.08
Biopsy
0
0.08
Colitis
0
0.08
Diet
0
0.08
Eosinophilia
0
0.08
Hand
0
0.08
Insurance
0
0.08
Interleukin
0
0.08
Monoclonal Antibody
0
0.08
North Carolina
0
0.08
Quality of Life
0
0.08
Receptors
0
0.08
Steroids
0
0.08
Specialty
Lead
score
Gastroenterology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Allergy & Clinical Immunology
0
0.7
Pathology & Lab Medicine
0
0.56
Pediatrics
0
0.23
Pharmacist
0
0.19
Edit Tags